Status:
COMPLETED
Pentraxin-3 in Hysterectomy Patients
Lead Sponsor:
Muğla Sıtkı Koçman University
Conditions:
Laparoscopic Hysterectomy
Abdominal Hysterectomy
Eligibility:
FEMALE
18+ years
Brief Summary
Comparison of the Tissue Trauma Markers Following Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy
Detailed Description
Acute trauma and major surgeries activate a series of cascades to evoke systemic inflammatory response. The magnitude of the resulting inflammatory response is proportional to the severity of the tiss...
Eligibility Criteria
Inclusion
- ·TLH+BSO patients and TAH+BSO patients
Exclusion
- History of a chronic disease (coronary artery disease, diabetes mellitus, hypertension, coronary liver failures, chronic kidney disease, chronic respiratory diseases, connective tissue disorders) which may affect levels of PTX-3 and other inflammatory markers.
- Prior surgery due to malignancy.
- History of an intra-abdominal surgery, except for cesarean section.
- History of any disease which may lead to intra-abdominal adhesions (endometriosis, past pelvic infection).
Key Trial Info
Start Date :
January 13 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 7 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04366375
Start Date
January 13 2015
End Date
December 7 2015
Last Update
April 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.